Clinical trials
Neuroma, Acoustic trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2005 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 4 |
| 2011 | 2 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Recruiting | 6 |
| Terminated | 5 |
| Withdrawn | 4 |
| Active, not recruiting | 3 |
| Unknown status | 3 |
| Enrolling by invitation | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Massachusetts Eye and Ear Infirmary | 4 |
| NYU Langone Health | 3 |
| Akouos, Inc. | 2 |
| Henry Ford Health System | 2 |
| Mayo Clinic | 2 |
| National Cancer Institute (NCI) | 2 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 2 |
| Children's Hospital Medical Center, Cincinnati | 1 |
| Eben Rosenthal | 1 |
| Emory University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neuroma, Acoustic | 39 |
| Neurofibromatosis 2 | 14 |
| Meningioma | 12 |
| Ependymoma | 7 |
| Brain Neoplasms | 6 |
| Glioma | 5 |
| Neurilemmoma | 5 |
| Vestibular Diseases | 5 |
| Glioblastoma | 4 |
| Astrocytoma | 3 |
Trials
Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.